ScienceDex / Researcher record
Kevin Urdahl
- Seattle Children's Hospital · Microbiology & Immunology (topic-inferred)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $5,443,065 | 1 | #962 |
| 2025 | $4,805,147 | 1 | #1,495 |
| 2026 | $3,934,592 | 1 | #4,251 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected1 record
- FY20251 record
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79953721Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award records by amount
NIH award records listing Kevin Urdahl as a PI. Multi-PI records show the full award amount for context.
- 75N93019C00070-P00021-9999-2N01Contact PIImmune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)Seattle Children's Hospital · Microbiology & Immunology (topic-inferred)$5.4Maward amount
Award organization
Organizations that administered FY2024 awards listing Kevin Urdahl as a PI.
FY2024 award administered by Seattle Children's Hospital (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSeattle Children's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #962
- 2024Entered Top 25% NationallyRanked #962
- 2024Entered Top 10% NationallyRanked #962
- 2024Entered Top 5% NationallyRanked #962
- 2025$10M Cumulative Funding